97 related articles for article (PubMed ID: 2805261)
21. Improved myocardial oxygen utilization by diltiazem in patients.
Kern MJ; Walsh RA; Barr WK; Porter CB; O'Rourke RA
Am Heart J; 1985 Nov; 110(5):986-90. PubMed ID: 4061275
[TBL] [Abstract][Full Text] [Related]
22. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
[TBL] [Abstract][Full Text] [Related]
23. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
24. Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatment.
Grover GJ; Sleph PG; Parham CS
J Pharmacol Exp Ther; 1988 Jul; 246(1):263-9. PubMed ID: 3392657
[TBL] [Abstract][Full Text] [Related]
25. Effect of diltiazem on myocardial blood flow.
Bache RJ; Dymek DJ
Circulation; 1982 Jan; 65(1 Pt 2):I19-26. PubMed ID: 7053295
[TBL] [Abstract][Full Text] [Related]
26. Coronary dilator effect of MCI-176, a new calcium channel blocker, in dogs.
Horii D; Ishibashi A
Tohoku J Exp Med; 1986 Sep; 150(1):101-2. PubMed ID: 3775769
[TBL] [Abstract][Full Text] [Related]
27. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
Fugit MD; Rubal BJ; Donovan DJ
J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic and metabolic effects of diltiazem during coronary sinus pacing with particular reference to left ventricular ejection fraction.
Josephson MA; Hopkins J; Singh BN
Am J Cardiol; 1985 Feb; 55(4):286-90. PubMed ID: 3969863
[TBL] [Abstract][Full Text] [Related]
29. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine.
Rossen JD; Quillen JE; Lopez AG; Stenberg RG; Talman CL; Winniford MD
J Am Coll Cardiol; 1991 Aug; 18(2):485-91. PubMed ID: 1856416
[TBL] [Abstract][Full Text] [Related]
30. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
[TBL] [Abstract][Full Text] [Related]
31. [Can adenosine triphosphate induce maximal hyperemic response in patients with impaired coronary microcirculation?: comparison of hyperemic response to adenosine triphosphate administered by intravenous and by intracoronary injection using Doppler guide wire].
Yanagi S; Hirota K; Nagae K; Abe Y; Hasegawa T; Okada M; Ota T; Yoshikawa J
J Cardiol; 2002 Jan; 39(1):1-10. PubMed ID: 11828792
[TBL] [Abstract][Full Text] [Related]
32. Postocclusion hyperemia provides a better estimate of coronary reserve than intracoronary adenosine in patients with coronary artery stenosis.
Nitenberg A; Durand E; Delatour B; Sdiri W; Raha S; Lafont A
J Invasive Cardiol; 2007 Sep; 19(9):390-4. PubMed ID: 17827509
[TBL] [Abstract][Full Text] [Related]
33. Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs.
Matsuzaki M; Gallagher KP; Patritti J; Tajimi T; Kemper WS; White FC; Ross J
Circulation; 1984 Apr; 69(4):801-14. PubMed ID: 6697464
[TBL] [Abstract][Full Text] [Related]
34. Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs.
Tilton GD; Bush LR; Apprill PG; Buja LM; Willerson JT
Circulation; 1985 Jan; 71(1):165-75. PubMed ID: 3964719
[TBL] [Abstract][Full Text] [Related]
35. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Takahashi T; Takahashi K; Kishi-Tanikawa S; Tsuchida K; Araki H; Higuchi S
J Pharmacol Exp Ther; 1996 Sep; 278(3):1028-33. PubMed ID: 8819482
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.
Bourassa MG; Cote P; Theroux P; Tubau JF; Genain C; Waters DD
Chest; 1980 Jul; 78(1 Suppl):224-30. PubMed ID: 7398410
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic changes after subselective intracoronary administration of nisoldipine in humans.
Vrolix MC; Sionis D; Piessens J; de Scheerder I; Willems JL; De Geest H
J Cardiovasc Pharmacol; 1991 Sep; 18(3):342-8. PubMed ID: 1720833
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Urquhart J; Epstein SE; Patterson RE
Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
[TBL] [Abstract][Full Text] [Related]
39. Specific coronary hemodynamic effects of nisoldipine and other vasoactive drugs.
Vrolix M; Piessens J
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S43-9. PubMed ID: 1282613
[TBL] [Abstract][Full Text] [Related]
40. Effect of diltiazem on experimental coronary artery thrombosis in dogs.
Schumacher WA; Lucchesi BR
Pharmacology; 1990; 41(1):16-23. PubMed ID: 2236203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
